{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:15:41Z","timestamp":1782544541356,"version":"3.54.5"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Tuberculosis is a contagious bacterial disease caused by <jats:italic>Mycobacterium tuberculosis<\/jats:italic>. The emergence and spread of drug-resistant strains of <jats:italic>M. tuberculosis<\/jats:italic> in both developing and developed countries has made diagnosis, treatment, and control of tuberculosis more difficult. The PCR assay, which is a fast and sensitive technique and an alternative method for detecting multidrug-resistant tuberculosis, is used to determine rifampicin (RIF) resistance. There is no single figure in Ethiopia that represents rifampicin-resistant tuberculosis and that is why this study was conducted to overcome the inconsistency of the results of the previous studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Studies were researched from five major electronic databases. Studies which were cross-sectional in design, published, and written in English were included. The data were extracted using Microsoft Excel, and the data were managed and analyzed using Stata\u2122 Version 17.0 statistical software. The Forest plot was used to check the presence of heterogeneity. The publication bias, meta-regression, and subgroup analysis were used to find out the source of heterogeneity. A random effect analysis model was used to pool the prevalence of RR TB from primary studies, and associated factors of RR among TB patients were identified using Meta regression. The presence of association was reported using OR with 95% CI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The overall pooled prevalence of tuberculosis was 14.9% (95% CI: 13.34, 16.46), of these approximately 7.48% (95% CI: 6.30, 8.66) showed rifampicin-resistant tuberculosis in Ethiopia. Among the computed variables, 2.05% living with HIV1.39 (95%CI: 1.13, 1.72) and having a history of TB treatment (95%CI: 1.34, 3.15) were identified as significant factors associated with RR TB in Ethiopia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Drug-resistant TB is one of the prevalent emerging infectious diseases among TB patients, which affects approximately one out of every thirteen TB patients. Having TB-HIV coinfection and a history of prior TB treatment were identified as significant factors associated with RR TB. To prevent and control RR TB, patients should complete their follow-up course; the health professionals should educate the actions taken by the patients when they experience drug toxicity and side effects; and the Minister of Health should initiate telemedicine and recruit tracers to overcome TB patients\u2019 default and have good drug adherence and retention after initiation of the treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1319845","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:51:17Z","timestamp":1718131877000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular detection of rifampicin-resistant Mycobacterium tuberculosis by polymerase chain reaction in Ethiopia: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Molla Yigzaw","family":"Birhanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getamesay Molla","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selamawit Shita","family":"Jemberie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"ref1","volume-title":"Patient education: Tuberculosis (Beyond the Basics)","author":"Murphy","year":""},{"key":"ref2","first-page":"S54","article-title":"Pulmonary tuberculosis among patients visiting a voluntary confidential counseling and testing center, Cambodia","volume":"12","author":"Chheng","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/clinids\/24.Supplement_1.S121","article-title":"Drug-resistant tuberculosis: review of the worldwide situation and the WHO\/IUATLD global surveillance project","volume":"24","author":"Cohn","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0140-6736(12)60734-X","article-title":"Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study","volume":"380","author":"Dalton","year":"2012","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref6","volume-title":"Global Tuberculosis Report","year":"2016"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1001\/jama.283.19.2537","article-title":"Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries","volume":"283","author":"Espinal","year":"2000","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3346\/jkms.2012.27.10.1143","article-title":"Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus\/mycobacterium tuberculosis co-infected patients in Korea","volume":"27","author":"Joh","year":"2012","journal-title":"J Korean Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0140-6736(93)90417-F","article-title":"Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis","volume":"341","author":"Telenti","year":"1993","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1164\/arrd.1986.133.3.423","article-title":"Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis","volume":"133","author":"Mitchison","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-18","article-title":"Rifampicin mono-resistant tuberculosis in France: a 2005\u20132010 retrospective cohort analysis","volume":"14","author":"Meyssonnier","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1128\/JCM.03533-13","article-title":"Multicenter feasibility study to assess external quality assessment panels for Xpert MTB\/RIF assay in South Africa","volume":"52","author":"Scott","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"27949","DOI":"10.3402\/gha.v8.27949","article-title":"Prevalence of tuberculosis, HIV, and TB-HIV co-infection among pulmonary tuberculosis suspects in a predominantly pastoralist area, Northeast Ethiopia","volume":"8","author":"Belay","year":"2015","journal-title":"Glob Health Action"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2047-2994-3-31","article-title":"Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care","volume":"3","author":"Biadglegne","year":"2014","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/HIV.S284722","article-title":"TB and HIV epidemiology and collaborative service: evidence from Ethiopia, 2011\u20132015","volume":"12","author":"Gelaw","year":"2020","journal-title":"HIV\/AIDS"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1371\/journal.pmed.0050225","article-title":"The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis","volume":"5","author":"Fazel","year":"2008","journal-title":"PLoS Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000454881","article-title":"Li Y-CJ, Shabbir S-A: benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis","volume":"47","author":"Islam","year":"2016","journal-title":"Neuroepidemiology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e0222572","DOI":"10.1371\/journal.pone.0222572","article-title":"The impact of peer pressure on cigarette smoking among high school and university students in Ethiopia: a systemic review and meta-analysis","volume":"14","author":"Leshargie","year":"2019","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0198091","DOI":"10.1371\/journal.pone.0198091","article-title":"Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda","volume":"13","author":"Kigozi","year":"2018","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4314\/ahs.v18i3.2","article-title":"Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria","volume":"18","author":"Adejumo","year":"2018","journal-title":"Afr Health Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.18203\/2394-6040.ijcmph20182039","article-title":"Prevalence of rifampicin resistant mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients in eastern Uttar Pradesh: a cross sectional study","volume":"5","author":"Gautam","year":"2018","journal-title":"Int J Community Med Public Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(95)91074-3","article-title":"Rifampicin-resistant Mycobacterium tuberculosis","volume":"345","author":"Weltman","year":"1995","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1514.e1","DOI":"10.1016\/j.cmi.2020.12.020","article-title":"Detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary samples with the FluoroType MTBDR assay","volume":"27","author":"Svensson","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.4269\/ajtmh.16-0120","article-title":"Rapid detection of Mycobacterium tuberculosis strains resistant to isoniazid and\/or rifampicin: standardization of multiplex polymerase chain reaction analysis","volume":"95","author":"Collantes","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tube.2012.10.013","article-title":"Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis","volume":"93","author":"de Knegt","year":"2013","journal-title":"Tuberculosis (Edinb)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7705\/biomedica.v37i1.3174","article-title":"Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType\u00ae MTBDRplus V.2 in Colombia","volume":"37","author":"Llerena","year":"2017","journal-title":"Biomedica"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/jac\/dkv406","article-title":"New insights into the survival mechanisms of rifampicin-resistant Mycobacterium tuberculosis","volume":"71","author":"Loots du","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijid.2015.06.013","article-title":"Multidrug-resistant and heteroresistant mycobacterium tuberculosis and associated gene mutations in Ethiopia","volume":"39","author":"Mekonnen","year":"2015","journal-title":"Int J Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nmni.2017.02.003","article-title":"Mycobacterium tuberculosis in Central Ethiopia: drug sensitivity patterns and association with genotype","volume":"17","author":"Bedewi","year":"2017","journal-title":"New Microbes New Infect"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12879-021-05961-8","article-title":"Phenotypic and genotypic drug sensitivity profiles of Mycobacterium tuberculosis infection and associated factors in northeastern Ethiopia","volume":"21","author":"Gashaw","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nmni.2017.10.009","article-title":"Genotyping and molecular detection of multidrug-resistant Mycobacterium tuberculosis among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia","volume":"21","author":"Zewdie","year":"2018","journal-title":"New Microbes New Infect"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s40121-020-00368-5","article-title":"Prevalence of Mycobacterium tuberculosis (rifampicin-resistant MTB) and associated risk actors among pulmonary presumptive TB patients in eastern Amhara, Ethiopia: 2015\u20132019","volume":"10","author":"Wasihun","year":"2021","journal-title":"Infect Dis Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1250404","article-title":"Detection of mycobacterium tuberculosis and rifampicin resistance using GeneXpert MTB\/RIF assay at Enat hospital, Central Ethiopia","volume":"2022","author":"Selfegna","year":"2022","journal-title":"Tuberc Res Treat"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-2328-4","article-title":"Rifampicin-resistance pattern of mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos referral hospital, Ethiopia: a cross-sectional study","volume":"10","author":"Mulu","year":"2017","journal-title":"BMC Res Notes"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4241-7","article-title":"Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia","volume":"19","author":"Sinshaw","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3943-1","article-title":"Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia","volume":"19","author":"Arega","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1202-7","article-title":"Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia","volume":"15","author":"Mekonnen","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref40","volume-title":"Wasihun AG: Prevalence of mycobacterium tuberculosis and rifampicin-resistant tuberculosis among tuberculosis presumptive adults in Northern Ethiopia, 2016-2019","author":"Dejene","year":"2021"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.2147\/IDR.S263023","article-title":"Rifampicin-resistant Mycobacterium tuberculosis among patients with presumptive tuberculosis in Addis Ababa, Ethiopia","volume":"13","author":"Araya","year":"2020","journal-title":"Infect Drug Resist"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2147\/IDR.S248059","article-title":"Prevalence of tuberculosis by automated GeneXpert rifampicin assay and associated risk factors among presumptive pulmonary tuberculosis patients at Ataye District hospital, north East Ethiopia","volume":"13","author":"Gebretsadik","year":"2020","journal-title":"Infect Drug Resist"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3855\/jidc.10462","article-title":"Rifampicin resistant tuberculosis in presumptive pulmonary tuberculosis cases in Dubti hospital, Afar, Ethiopia","volume":"13","author":"Gebrehiwet","year":"2019","journal-title":"J Infect Dev Ctries"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-652594\/v1","volume-title":"Rifampicin-resistance pattern of mycobacterium tuberculosis and associated risk factors among presumptive pulmonary and extra pulmonary tuberculosis patients at Madda Walabu University Goba referral hospital, Southeast Ethiopia","author":"Kelecha","year":"2021"},{"key":"ref45","first-page":"60","article-title":"Xpert MTB\/RIF assay for the diagnosis of mycobacterium tuberculosis and its rifampicin resistance at Felege Hiwot and Debre Tabor hospitals, Northwest Ethiopia: a preliminary implementation research","volume":"30","author":"Derbie","year":"2016","journal-title":"Ethiop J Health Dev"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/IDR.S135935","article-title":"Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, Northwest Ethiopia","volume":"10","author":"Jaleta","year":"2017","journal-title":"Infect Drug Resist"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2147\/IDR.S300585","article-title":"Magnitude of Mycobacterium tuberculosis infection and its resistance to rifampicin using Xpert-MTB\/RIF assay among presumptive tuberculosis patients at Motta general hospital, Northwest Ethiopia","volume":"14","author":"Demissie","year":"2021","journal-title":"Infect Drug Resist"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.2147\/IDR.S327607","article-title":"The magnitude of MTB and rifampicin resistance MTB using Xpert-MTB\/RIF assay among tuberculosis suspected patients in Gedeo zone, southern Ethiopia","volume":"14","author":"Diriba","year":"2021","journal-title":"Infect Drug Resist"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.2147\/IDR.S274589","article-title":"Rifampicin-resistant multidrug-resistant tuberculosis cases in selected hospitals in Western Oromia, Ethiopia: cross-sectional retrospective study","volume":"13","author":"Zewdie","year":"2020","journal-title":"Infect Drug Resist"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e16137","DOI":"10.1371\/journal.pone.0016137","article-title":"Secondary attack rate of tuberculosis in urban households in Kampala, Uganda","volume":"6","author":"Whalen","year":"2011","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1016\/S2666-5247(21)00044-6","article-title":"Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study","volume":"2","author":"Z\u00fcrcher","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4375-7","article-title":"Prevalence and factors associated with multidrug\/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana","volume":"19","author":"Tembo","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0180996","DOI":"10.1371\/journal.pone.0180996","article-title":"Prevalence of drug-resistant tuberculosis in Nigeria: a systematic review and meta-analysis","volume":"12","author":"Onyedum","year":"2017","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"203","DOI":"10.11604\/pamj.2021.38.203.19034","article-title":"Prevalence of rifampicin resistance tuberculosis among HIV\/TB coinfected patients in Benue state, Nigeria","volume":"38","author":"Ejeh","year":"2021","journal-title":"Pan Afr Med J"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/HIV.S193059","article-title":"Drug-resistant tuberculosis and HIV infection: current perspectives","volume":"12","author":"Singh","year":"2020","journal-title":"HIV\/AIDS"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e0270003","DOI":"10.1371\/journal.pone.0270003","article-title":"Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis","volume":"17","author":"Xi","year":"2022","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/thx.2005.045963","article-title":"Risk factors for multi-drug resistant tuberculosis in Europe: a systematic review","volume":"61","author":"Faustini","year":"2005","journal-title":"Thorax"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3390\/antibiotics10080932","article-title":"Prevalence of drug-resistant tuberculosis in Sudan: a systematic review and meta-analysis","volume":"10","author":"Hajissa","year":"2021","journal-title":"Antibiotics"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1319845\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:51:24Z","timestamp":1718131884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1319845\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":58,"alternative-id":["10.3389\/fmed.2024.1319845"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1319845","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]},"article-number":"1319845"}}